PRIMARY LYMPH NODE PLASMACYTOMA – A RARE CLINICAL ENTITY
Abstract
Introduction: Extramedullary plasmacytoma localized in the region of the head and neck represents less than 1% of tumors found in that region. Primary solitary localization of plasmacytoma in the lymph node, as the only manifestation of plasmacytoma, is rare, with less than 50 cases reported so far.
Case report: A 58-year-old man came to the physician because of a painless swollen lymph node in the neck, afebrile, reporting no night sweats or weight loss. He was treated with broad-spectrum antibiotics for 10 days, but his health status did not change. A complete blood count (CBC) was performed, and normal test results were obtained. The patient tested negative for biohumoral inflammatory syndrome. The ultrasound examination of the neck showed a lymph gland, 30 mm x 15 mm in size. The patient was referred to a maxillofacial surgeon; total lymph node extirpation was performed, and the excised node was sent for histopathological analysis. The following pathohistological finding was obtained: diffuse infiltration by plasmacytoid tumor cells stronlgly positive for: OCT2, BOB1, CD38, MUM1, lambda, CD31, VIM, and CD79 alpha; negative for kappa; positive for Ki67 in 30%. The conclusion of the pathohistological examination was lambda positive plasmacytoma. Bone biopsy showed the following: plasmocytes 4%. The findings of multi-slice computed tomography (MSCT) of the thorax, abdomen, and lesser pelvis were normal. Radiographic imaging of the skeleton also showed normal findings. The M protein, in both serum and urine, was negative. Virology tests showed that the patient was HBsAg positive, while he was HCV and HIV negative. Local radiation therapy was indicated along with active antiviral therapy.
Conclusion: Each case of lymphadenopathy demands a serious and thorough approach to be established by the clinician. The question is whether an infection caused by the Hepatitis B virus may have served as a trigger for the development of plasmacytoma.
References
Guedes A, Becker RG, Teixeira LEM. Multiple Myeloma (Part 1) – Update on epidemiology, diagnostic criteria, systemic treatment and prognosis. Rev Bras Ortop (Sao Paulo). 2023 Jun 29;58(3):361-7. doi: 10.1055/s-0043-1770149.
Silva ROP, Brandão KMA, Pinto PVM, Faria RMD, Clementino NCD, Silva CMF, et al. Mieloma múltiplo: características clínicas e laboratoriais ao diagnóstico e estudo prognóstico. Rev Bras Hematol Hemoter. 2009;31(02):63-8. doi: 10.1590/S1516-84842009005000013.
Ponte FM, Garcia Filho RJ, Hadler MB, Korukian M, Ishihara HY. Avaliação do tratamento ortopédico no mieloma múltiplo. Rev Bras Ortop. 2002;37(05):162-70.
Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 May;95(5):548-67. doi: 10.1002/ajh.25791.
American Cancer Society [Internet]. Atlanta American Cancer Society; c2020. About multiple myeloma [Accessed: 12. 3. 2020.]. Available from: https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-myeloma.html.
Sucro LV, Silva JCML, Gehlen GW, Eldin JFS, Amaral GA, Santana MAP. Mieloma múltiplo: diagnóstico e tratamento. Rev Med Minas Gerais 2009;19(01):58-62.
Guedes A, Becker RG, Teixeira LEM. Multiple Myeloma (Part 2) - Update on the approach to bone disease. Rev Bras Ortop (Sao Paulo). 2023 Jun 29;58(3):368-7. doi: 10.1055/s-0043-1770150.
Batsakis JG, Medeiros JL, Luna MA, El-Naggar AK. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol. 2002 Apr;6(2):129-40. doi: 10.1053/adpa.2002.33458.
Menke DM, Horny HP, Griesser H, Tiemann M, Katzmann JA, Kaiserling E, et al. Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol. 2001 Jan;115(1):119-26. doi: 10.1309/L2GR-PCFM-G4A3-GHDW.
Lim YH, Park SK, Oh HS, Choi JH, Ahn MJ, Lee YY, et al. A case of primary plasmacytoma of lymph nodes. Korean J Intern Med. 2005 Jun;20(2):183-6. doi: 10.3904/kjim.2005.20.2.183.
Woodruff RK, Whittle JM, Malpas JS. Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma. Cancer. 1979 Jun;43(6):2340-3. doi: 10.1002/1097-0142(197906)43:6<2340:aid-cncr2820430625>3.0.co;2-m.
Pantelidou D, Tsatalas C, Margaritis D, Karayiannakis AJ, Kaloutsi V, Spanoudakis E, et al. Extramedullary plasmacytoma: report of two cases with uncommon presentation. Ann Hematol. 2005 Mar;84(3):188-91. doi: 10.1007/s00277-004-0854-y.
Alfar R, Al-Shatti M, Alomari Z, Bater R, Rahal R, Abdel-Razeq R, et al. Primary extra-medullary plasmacytoma with lymph node involvement, lymphoma mimicry: a case report and review of the literature. Med Case Rep. 2022;8(6):230. doi: 10.36648/2471-8041.8.6.230.
Gerry D, Lentsch EJ. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck. Otolaryngol Head Neck Surg. 2013 Jun;148(6):974-81. doi: 10.1177/0194599813481334.
Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999 Jun 1;85(11):2305-14. doi: 10.1002/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3.
Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore). 1976 May;55(3):217-38. doi: 10.1097/00005792-197605000-00002.
Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica. 2000 Jan;85(1):47-51.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al; Guidelines Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004 Mar;124(6):717-26. doi: 10.1111/j.1365-2141.2004.04834.x.
